Dr. Janet Woodcock will assume the role of acting director of the Center for Drug Evaluation and Research (CDER) as the center’s previous director, Dr. Steven Galson, becomes acting surgeon general.

Woodcock will retain her position as deputy commissioner and permanent chief medical officer, and will work with FDA Commissioner Andrew von Eschenbach to launch a national search for a permanent director of the center, the FDA said.

Of Galson, von Eschenbach said: “Because of his accomplishments, Americans have access to safer and more effective medical products than ever before. I know Steven will excel as our nation’s chief health educator and Americans will continue to benefit from his dedication to public service.”